Concepedia

M.A. Wadud Khan

MW

Statistics

Publications

11

Citations

1.6K

H-Index

11

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas at Arlington

Parker Institute for Cancer Immunotherapy

Monash University

European Institute of Oncology

M.A. Wadud Khan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, microbiology, and microbiome.

ORCID

Top concepts

Publications per year

2018–2022

11

Publications

11

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 582 citations · Full text

, , +6

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan et al. · Nature Medicine · 2021 · 388 citations · Full text

, , +13

Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia

Jessica Galloway-Peña, Yushu Shi, Christine B. Peterson et al. · Clinical Infectious Diseases · 2019 · 124 citations · Full text

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Christopher P. Vellano, Michael G. White, Miles C. Andrews et al. · Nature · 2022 · 124 citations · Full text

, , +6

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Tina Cascone, Annikka Weissferdt, Myrna C. B. Godoy et al. · Nature Communications · 2021 · 102 citations · Full text

1–5 of 11